FDA grants regular approval to venetoclax in combination for untreated acute myeloid leukemia

Trial

Viale-a

Drugs

VENCLEXTA (venetoclax) · Bcl-2 inhibitor, azacitidine · DNA methyltransferase inhibitor

Conditions

MyeloidOther hematologic neoplasm